Ubiquitination as an acute regulator of synaptic transmission

泛素化作为突触传递的急性调节因子

基本信息

  • 批准号:
    8286850
  • 负责人:
  • 金额:
    $ 19.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Synaptic transmission is a critical feature of the nervous system and is as such tightly regulated on many different time-scales. The ubiquitin-proteasome system (UPS) plays an important role in synaptic transmission by maintaining appropriate protein homeostasis. The UPS regulates synapse formation during development, by shaping long-term plasticity, by altering the number of active synapses and by changing the size of vesicle pools. All of these regulatory functions occur on a time scale of hours to days and are consistent with the central role of the UPS in protein degradation: covalent attachment of ubiquitin tags proteins for degradation by the proteasome. We have recently discovered that the UPS also regulates neurotransmitter release on a time-scale of a few minutes or less. This led us to the hypothesis that ubiquitination at the synapse rapidly regulates release by changing the activity level of target proteins rather than changing their half-life. Thus, protein ubiquitination can serve as an acute dynamic regulator of synaptic function. This represents a novel regulatory pathway that is of clear basic science interest given the central role of synaptic transmission in nervous system function. However, the pathway is also of clear clinical interest as it might offer insight into the earliest steps of dysfunction associated with neurodegenerative diseases. In many neurodegenerative diseases signs of synaptic dysfunction precede clinical symptoms. Neurodegenerative diseases are also characterized by a UPS that is impaired either through mutations in the pathway, by misfolded proteins or via environmental toxins. The recognition of the rapid regulatory role of the UPS in shaping synaptic transmission might offer an early causal link between UPS impairment and synaptic dysfunction. In this grant application we will test the physiological mechanisms that mediate the rapid regulation of presynaptic release by ubiquitination (Aim 1). Together with the identification of the synaptic ubiquitome (Aim2) these experiments will enable discovery of pathways and processes that are of basic science interest and that might provide novel druggable targets for neurological diseases.
描述(由申请人提供):突触传递是神经系统的一个关键特征,因此在许多不同的时间尺度上受到严格的调节。泛素-蛋白酶体系统(UPS)通过维持适当的蛋白质稳态在突触传递中起着重要作用。在发育过程中,UPS通过塑造长期可塑性,通过改变活跃突触的数量和改变囊泡池的大小来调节突触的形成。所有这些调节功能都发生在数小时至数天的时间尺度上,并且与UPS在蛋白质降解中的核心作用一致:泛素标签蛋白的共价连接用于蛋白酶体的降解。我们最近发现UPS还在几分钟或更短的时间内调节神经递质的释放。这使我们提出了这样的假设:突触处的遍在化通过改变靶蛋白的活性水平而不是改变它们的活性水平来快速调节释放。半衰期。因此,蛋白质泛素化可以作为突触功能的急性动态调节剂。这代表了一种新的调节途径,具有明确的基础科学兴趣,因为突触传递在神经系统功能中起着核心作用。然而,该途径也具有明确的临床意义,因为它可能提供与神经退行性疾病相关的功能障碍的最早步骤的见解。在许多神经退行性疾病中,突触功能障碍的迹象先于临床症状。神经退行性疾病的特征还在于UPS通过通路中的突变、通过错误折叠的蛋白质或通过环境毒素而受损。UPS在塑造突触传递中的快速调节作用的认识可能提供UPS损伤和突触功能障碍之间的早期因果关系。在这项资助申请中,我们将测试介导突触前释放的泛素化(目标1)的快速调节的生理机制。这些实验与突触泛素组(Aim 2)的鉴定一起,将能够发现具有基础科学意义的途径和过程,并可能为神经系统疾病提供新的药物靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FELIX E SCHWEIZER其他文献

FELIX E SCHWEIZER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FELIX E SCHWEIZER', 18)}}的其他基金

2012 Synaptic Transmission Gordon Research Conference
2012年突触传递戈登研究会议
  • 批准号:
    8318942
  • 财政年份:
    2012
  • 资助金额:
    $ 19.25万
  • 项目类别:
Ubiquitination as an acute regulator of synaptic transmission
泛素化作为突触传递的急性调节因子
  • 批准号:
    8174415
  • 财政年份:
    2011
  • 资助金额:
    $ 19.25万
  • 项目类别:
Indicators of early neurodegeneration: gene-toxin interactions at the syanpse
早期神经退行性变的指标:突触处的基因-毒素相互作用
  • 批准号:
    7707066
  • 财政年份:
    2009
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    7856020
  • 财政年份:
    2009
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    7091346
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    7237323
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    6965360
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    7628704
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    7433762
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:
Molecular mechanisms of vestibular hair cell exocytosis
前庭毛细胞胞吐作用的分子机制
  • 批准号:
    7640968
  • 财政年份:
    2005
  • 资助金额:
    $ 19.25万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 19.25万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了